NCT03556904 2026-01-15
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
Phase 2 Completed
Clinical Trials
24 trialsNCT02454543 2026-01-12
g-RAMPP
Martini-Klinik am UKE GmbH
Phase NA Active not recruiting
NCT06120374 2025-12-30
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Recruiting
NCT07261592 2025-12-03
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Not yet recruiting
NCT07163910 2025-11-18
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
Zhongda Hospital
Phase 2 Recruiting
NCT06727214 2025-09-30
AssiutU
Assiut University
Not yet recruiting
NCT02649829 2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2 Completed
NCT00938145 2025-04-11
3 Tesla MRI in Patients With Bladder Cancer
University of Cincinnati
Phase NA Active not recruiting
NCT06686381 2025-02-05
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
Phase 2 Not yet recruiting
NCT03248570 2024-11-20
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
Phase 2 Completed
NCT00321698 2024-08-29
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
OHSU Knight Cancer Institute
Phase 1/2 Terminated
NCT06531629 2024-08-06
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Completed
NCT06427057 2024-05-23
A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors
Tongji Hospital
Phase 2 Not yet recruiting
NCT03700099 2024-04-15
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
Instituto do Cancer do Estado de São Paulo
Phase 2 Active not recruiting
NCT06350825 2024-04-05
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Recruiting
NCT05429515 2022-06-23
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Peking Union Medical College Hospital
Phase 4 Not yet recruiting
NCT05082818 2022-06-14
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Completed
NCT04588168 2020-10-19
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT01993979 2020-05-04
POUT
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT00002677 2019-11-04
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
University of Maryland, Baltimore
Phase 1 Completed
NCT01811810 2019-04-23
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT03524391 2018-05-14
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients
NMP Medical Research Institute
Phase NA Completed
NCT00005848 2013-07-11
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Fox Chase Cancer Center
Phase 2 Completed
NCT00179816 2010-10-11
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Unknown